MARKET

CELZ

CELZ

Creative Med Technology Hldgs
NASDAQ
4.820
-0.010
-0.21%
Closed 16:00 04/23 EDT
OPEN
4.860
PREV CLOSE
4.830
HIGH
4.930
LOW
4.820
VOLUME
9.60K
TURNOVER
0
52 WEEK HIGH
10.28
52 WEEK LOW
3.930
MARKET CAP
6.54M
P/E (TTM)
-1.2834
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CELZ last week (0415-0419)?
Weekly Report · 1d ago
Weekly Report: what happened at CELZ last week (0408-0412)?
Weekly Report · 04/15 10:22
Weekly Report: what happened at CELZ last week (0401-0405)?
Weekly Report · 04/08 10:25
Weekly Report: what happened at CELZ last week (0325-0329)?
Weekly Report · 04/01 10:24
Creative Medical Technology Holdings Inc reports results for the quarter ended in December - Earnings Summary
Creative Medical Technology Holdings Inc reports results for the quarter ended in December. The company reported a quarterly adjusted loss of $1.19 per share. Revenue fell 84.2% to $3.00 thousand from a year ago. Shares had risen by 12.6% this quarter.
Reuters · 03/25 21:01
Weekly Report: what happened at CELZ last week (0318-0322)?
Weekly Report · 03/25 10:26
Creative Medical Technology Holdings Inc <CELZ.OQ> expected to post a loss of $1.13 a share - Earnings Preview
Creative Medical Technology Holdings Inc expected to post a loss of $1.13 a share - Earnings Preview. The one available analyst rating on the shares is "buy" for the company. The company is expected to show a fall in quarterly revenue when it reports results.
Reuters · 03/22 20:17
Weekly Report: what happened at CELZ last week (0311-0315)?
Weekly Report · 03/18 10:25
More
About CELZ
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.

Webull offers Creative Medical Technology Holdings Inc stock information, including NASDAQ: CELZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CELZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CELZ stock methods without spending real money on the virtual paper trading platform.